Drug-induced methemoglobinemia.
D000700:Analgesics / Q000009:adverse effects; D000779:Anesthetics, Local / Q000009:adverse effects; D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D002415:Cats; D004285:Dogs; D005078:Exchange Transfusion, Whole Blood; D005984:Glutethimide / Q000009:adverse effects; D006168:Guinea Pigs; D006453:Hemoglobinopathies / Q000235:genetics; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D006898:Hydroxylamines / Q000627:therapeutic use; D006931:Hyperbaric Oxygenation; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000503:physiopathology / Q000628:therapy; D008751:Methylene Blue / Q000627:therapeutic use; D051379:Mice; D010084:Oxidation-Reduction; D010672:Phenytoin / Q000009:adverse effects; D014665:Vasodilator Agents / Q000009:adverse effects
D000700:Analgesics; D000779:Anesthetics, Local; D000890:Anti-Infective Agents; D000925:Anticoagulants; D006454:Hemoglobins; D006898:Hydroxylamines; D014665:Vasodilator Agents; D010672:Phenytoin; D005984:Glutethimide; D008751:Methylene Blue